Neuroendocrine Tumors Market is driven by targeted therapies

ha aggiunto una foto Health

2025-06-17 06:41:50 -

Neuroendocrine tumors (NETs) are a heterogeneous group of malignancies arising from neuroendocrine cells in organs such as the pancreas, gastrointestinal tract, and lungs. Management options include somatostatin analogs, peptide receptor radionuclide therapy (PRRT), targeted therapies, and emerging immunomodulatory agents. The Global Neuroendocrine Tumors Market is estimated to be valued at...

0 Commenti 0 condivisioni 6 Views 0 Anteprima